İDİLMAN, R. Et Al. 2018. Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program. International Liver Congress (ILC) , (Paris, France).

İDİLMAN, R., Demir, M., ALADAĞ, M. A., KAYMAKOĞLU, S., EROL, Ç., ÇAVUŞ, B., ... Iliaz, R.(2018). Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program . International Liver Congress (ILC), Paris, France

İDİLMAN, RAMAZAN Et Al. "Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program," International Liver Congress (ILC), Paris, France, 2018

İDİLMAN, RAMAZAN Et Al. "Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program." International Liver Congress (ILC) , Paris, France, 2018

İDİLMAN, R. Et Al. (2018) . "Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program." International Liver Congress (ILC) , Paris, France.

@conferencepaper{conferencepaper, author={RAMAZAN İDİLMAN Et Al. }, title={Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program}, congress name={International Liver Congress (ILC)}, city={Paris}, country={France}, year={2018}}